In vitro model insights into the role of human gut microbiota on arsenic bioaccessibility and its speciation in soils

Show simple item record

dc.contributor.author Chi, Haifeng
dc.contributor.author Hou, Yanwei
dc.contributor.author Li, Guofeng
dc.contributor.author Zhang, Youchi
dc.contributor.author Coulon, Frederic
dc.contributor.author Cai, Chao
dc.date.accessioned 2020-04-24T14:06:59Z
dc.date.available 2020-04-24T14:06:59Z
dc.date.issued 2020-04-16
dc.identifier.citation Chi H, Hou Y, Li G,et al., (2020) In vitro model insights into the role of human gut microbiota on arsenic bioaccessibility and its speciation in soils, Environmental Pollution. Volume 263, Pt.A, August 2020, Article number 114580 en_UK
dc.identifier.issn 0269-7491
dc.identifier.uri https://doi.org/10.1016/j.envpol.2020.114580
dc.identifier.uri http://dspace.lib.cranfield.ac.uk/handle/1826/15412
dc.description.abstract The bioaccessibility of arsenic and its speciation are two important factors in assessing human health risks exposure to contaminated soils. However, the effects of human gut microbiota on arsenic bioaccessibility and its speciation are not well characterized. In this study, an improved in vitro model was utilized to investigate the bioaccessibility of arsenic in the digestive tract and the role of human gut microbiota in the regulation of arsenic speciation. For all soils, arsenic bioaccessibility from the combined in vitro model showed that it was <40% in the gastric, small intestinal and colon phases. This finding demonstrated that the common bioaccessibility approach assuming 100% bioaccessibility would overestimate the human health risks posed by contaminated soils. Further to this, the study showed that arsenic bioaccessibility was 22% higher in the active colon phase than that in the sterile colon phase indicating that human colon microorganisms could induce arsenic release from the solid phase. Only inorganic arsenic was detected in the gastric and small intestinal phases, with arsenate [As(V)] being the dominant arsenic species (74%–87% of total arsenic). Arsenic speciation was significantly altered by the active colon microbiota, which resulted in the formation of methylated arsenic species, including monomethylarsonic acid [MMA(V)] and dimethylarsinic acid [DMA(V)] with low toxicity, and a highly toxic arsenic species monomethylarsonous acid [MMA(III)]. Additionally, a high level of monomethylmonothioarsonic acid [MMMTA(V)] (up to 17% of total arsenic in the extraction solution) with unknown toxicological properties was also detected in the active colon phase. The formation of various organic arsenic species demonstrated that human colon microorganisms could actively metabolize inorganic arsenic into methylated arsenicals and methylated thioarsenicals. Such transformation should be considered when assessing the human health risks associated with oral exposure to soil. en_UK
dc.language.iso en en_UK
dc.publisher Elsevier en_UK
dc.rights Attribution-NonCommercial-NoDerivatives 4.0 International *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/ *
dc.subject Soils en_UK
dc.subject Arsenic bioaccessibility en_UK
dc.subject Human gut microbiota en_UK
dc.subject In vitro models en_UK
dc.subject Health risk assessment en_UK
dc.title In vitro model insights into the role of human gut microbiota on arsenic bioaccessibility and its speciation in soils en_UK
dc.type Article en_UK


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

Search CERES


Browse

My Account

Statistics